Brazilian health authority on Wednesday said that a volunteer in a clinical trial of the COVID-19 vaccine being developed by Oxford University and AstraZeneca has died but added the trial would continue. Reports said the volunteer received a placebo and not the trial vaccine. Oxford said after careful assessment "there have been no concerns about safety of the clinical trial."